These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4307457)

  • 1. Stimulation and suppression of aldosterone in plasma of normal man and in primary aldosteronism.
    Horton R
    J Clin Invest; 1969 Jul; 48(7):1230-6. PubMed ID: 4307457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of aldosterone secretion in primary aldosteronism.
    Spark RF; Dale SL; Kahn PC; Melby JC
    J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism.
    Zoccali C; Usherwood T; Brown JJ; Lever AF; Robertson JI; Fraser R
    J Steroid Biochem; 1983 Jul; 19(1A):327-31. PubMed ID: 6310234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism.
    Wisgerhof M; Mellinger RC
    J Clin Endocrinol Metab; 1985 Jul; 61(1):192-5. PubMed ID: 2987293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin III and ACTH on aldosterone secretion.
    Zager PG; Luetscher JA
    Clin Exp Hypertens A; 1982; 4(9-10):1481-504. PubMed ID: 6291810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
    Ganguly A; Luetscher JA; Weinberger MH
    Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
    Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
    J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
    Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
    Guthrie GP
    J Lab Clin Med; 1981 Sep; 98(3):364-73. PubMed ID: 6267148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced aldosterone stimulation in man is not dependent upon adrenocorticotropin.
    Nicholls MG; Grekin RJ; Padfield PL
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1171-4. PubMed ID: 6252231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of adrenal function in man by heparin or heparinoid Ro 1-8307.
    Kloppenborg PW; Casparie AF; Benraad TJ; Majoor CL
    Acta Med Scand; 1975; 197(1-2):99-108. PubMed ID: 47702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma aldosterone levels in primary aldosteronism. II. Aldosterone and ACTH].
    Fukuchi S; Takenouchi T; Nakajima K; Sasaki C
    Nihon Naibunpi Gakkai Zasshi; 1973 Jul; 49(7):981-7. PubMed ID: 4353327
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma aldosterone response to ACTH in subtypes of primary aldosteronism.
    Stowasser M; Klemm SA; Tunny TJ; Gordon RD
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):460-2. PubMed ID: 8582103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II induces the release of 19-hydroxyandrostenedione in man.
    Sekihara H; Torii R; Osawa Y; Takaku F
    J Clin Endocrinol Metab; 1985 Aug; 61(2):291-6. PubMed ID: 2989318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone production after suppression of corticotropic secretory activity.
    Spark RF; Gordon SJ; Dale SL; Melby JC
    Arch Intern Med; 1968 Nov; 122(5):394-8. PubMed ID: 4301259
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism.
    Ganguly A; Weinberger MH; Guthrie GP; Fineberg NS
    Hypertension; 1984; 6(4):563-7. PubMed ID: 6086520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
    Kigoshi T; Iwasaki R; Kaneko M; Nakano S; Azukizawa S; Uchida K; Morimoto S
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secretory regulation and episodic secretion of aldosterone in patients with primary aldosteronism (author's transl)].
    Ohbuchi S; Murakami T
    Nihon Naibunpi Gakkai Zasshi; 1976 Dec; 52(12):1191-201. PubMed ID: 201513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism.
    Miyamori I; Koshida H; Matsubara T; Soma R; Takasaki H; Okamoto S; Takeda R
    Exp Clin Endocrinol; 1990 Aug; 95(3):323-9. PubMed ID: 2174003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.